Morning Movers
Watch us on YouTube Live at 8:30AM EST

TSLA.NQ 1.35%
Tesla Inc – The electric carmaker easily beat Wall Street expectations for second-quarter revenue on the back of record deliveries, despite the impact from a prolonged global shortage of chips and raw materials. The carmaker said revenue rose to $11.96 billion from $6.04 billion a year earlier, a nearly 50% increase despite a six week U.S. factory was shut down due to local lockdown orders aimed at curbing coronavirus. The results mark the eighth straight quarter of profit for the 18-year-old company, that earned $1.1 billion in the period, the first time its quarterly profit surpassed $1 billion. TSLA also reported a $23-million Bitcoin impairment and record quarterly deliveries.

Chinese Companies – Remain under pressure in early trading as Beijing continues to step up its tech crackdown. Tech giants Alibaba, Baidu,, Pinduoduo, Tencent Music and NetEase are all down sharply again between 5% and 8%. Ride-hailing firm Didi DIDI.N is down 6.8% while Chinese electric-vehicle makers Li Auto Inc, Nio Inc and Xpeng Inc are also looking at 4% declines premarket. Chinese regulators have vowed to strengthen the oversight of its big tech firms citing concerns they have built market power that stifles competition, misused consumer data and violated consumer rights. BABA, BIDU, JD, DIDI, LI, NIO, XPEV, TME, TAL, EDU, GOTU

UPS.NY -2.33%
United Parcel Service Inc – Beat Wall Street estimates for second-quarter profit and revenue on Tuesday, helped by e commerce deliveries, air shipments and specialized handling of healthcare products such as COVID-19 vaccines. Revenue in its core U.S. domestic unit rose 10.2%, while international segment jumped 30%, boosted by Europe. UPS has said rate hikes and increased business from small and medium-sized businesses are expected to generate about half of the margin in the company’s core U.S. market. Excluding items, UPS earned $3.06 per share in the second quarter, above analysts’ estimates, total revenue jumped 14.5% to $23.42 billion, beating estimates of $23.24 billion.

GE.NY 4.10%
General Electric – Reported quarterly adjusted earnings of 5 cents​​ per share in its latest quarter vs expectation of sixteen analysts for the quarter of earnings of 3 cents per share. Revenue rose 3% to $18.28 billion from a year ago; analysts expected $18.14 billion. General Electric Co’s reported EPS for the quarter was a loss of 14 cents​. The company reported a quarterly loss of $1.19 billion. GE also raised its full-year free cash flow guidance.

Crypto Stocks – Volatile 24hrs for BTC that once again slumped below $40,000 after the biggest crypto jumped over 17% in yesterday’s session following reports that Amazon would accept the digital currency as a form of payment by year-end. There was little foundation to the story other than some source reports but as with many crypto rallies, it only takes a rumor to convince traders to buy Bitcoin and lead into a rally. But the enthusiasm dried out into the evening as Amazon came out to deny the claims, calling it mere speculation. They did mention that they were interested in the crypto space and would continue exploring options, which has likely helped save some of yesterday’s rally. COIN, RIOT, MARA, BTBT, FTFT, SOS, SI, MSTR

XELA.NQ 17.89%
Exela Technologies – The business process automation (BPA) leader, today announced that its Digital Mailroom (“DMR”) and DrySign® offerings delivered a record addition of new users in the second quarter of 2021. DMR and Drysign continued to grow in the preceding 90 days with DMR delivering a growth rate of 99% in its SMB customer base and Drysign delivering a growth rate of 144% in its user base, as compared to the prior period.

TYME.NQ 2.90%
Tyme Technologies – Active in the premarket for the second straight session, Monday’s rally followed news the company had been granted U.S. patent for drug delivery platform.

EYEG.NQ 133.33%
Eyegate Pharmaceuticals – The micro-cap pharma is trading sharply higher on heavy volume premarket after announcing it has appointed Brian M. Strem as President and CEO, the company also said it has entered into a non-binding LOI to acquire Bayon Therapeutics.

OBSV.NQ 25.00%
Obseva SA – Shares are sharply higher after announcing a new licensing deal with Organon for preterm labor drug.

Leave a Reply

Your email address will not be published.